Crossmark

Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!

Crossref DOI link: https://doi.org/10.1186/s13104-021-05570-3

Published Online: 2021-04-20

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mveang Nzoghe, Amandine

Leboueny, Marielle

Kuissi Kamgaing, Eliane

Maloupazoa Siawaya, Anicet Christel

Bongho, Eliode Cyrien

Mvoundza Ndjindji, Ofilia

Padzys, Guy-Stephan

Ndeboko, Bénédicte

Ategbo, Simon

Djoba Siawaya, Joel Fleury https://orcid.org/0000-0002-0369-0153
Funding

Funding for this research was provided by:

CHU- Mère-Enfant ; Fondation Jeanne EBORI
License Information

Text and Data Mining valid from 2021-04-20

Version of Record valid from 2021-04-20
More Information

Article History

Received: 2 February 2021

Accepted: 13 April 2021

First Online: 20 April 2021

Declarations

:

: CHU- Mère-Enfant Fondation Jeanne EBORI board approved the study. All participants gave their consent after being informed of the study objectives. Consent was informed and obtained in a written or verbal format (both formats are allowed) based on participant preferences.

: Not Applicable.

: The authors declare no competing financial or non-financial interests concerning the present work.

Document is current

Any future updates will be listed below